 Home > Active Ingredient News > Antitumor Therapy > NEJM: Sotorasib treatment of KRASp.G12C mutant advanced non-small cell lung cancer Phase II clinical data is gratifying

NEJM: Sotorasib treatment of KRASp.G12C mutant advanced non-small cell lung cancer Phase II clinical data is gratifying

 Last Update: 2021-06-16
 Source: Internet
 Author: User

Tags

hiv injection treatment

chemotherapy drugs list

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

In recent years, thanks to targeted drugs and immunotherapy , significant progress has been made in the treatment of non-small cell lung cancer ( NSCLC ), and the mortality rate of patients has dropped significantly.

Immune NSCLC researchers recently announced the Phase II clinical study data of Sotorasib in the treatment of advanced NSCLC patients with KRAS p.

In this single-center phase II trial, the researchers investigated the efficacy of Sotorasib on advanced NSCLC patients with KRAS p.

Of the 126 patients, most (81.

46 patients responded to the treatment (37.

Progression-free survival after Sotorasib treatment, overall survival data

Studies believe that Sotorasib has shown good therapeutic effects and good safety in KRASp.

Sotorasib has shown good therapeutic effect and good safety in KRASp.

Original source:

Ferdinandos Skoulidis et al.

Sotorasib for Lung Cancers with KRAS p.
G12C Mutation.

Leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane 53-19-0

CAS No.: 53-19-0

Pharmacy Grade

$100/KG EXW

High Quality Resveratrol 99% powder 501-36-0 Shaanxi Dideu Medichem Co.Ltd

CAS No.: 501-36-0

Chemical Grade

$1/KG FOB

High purity Epirubicin hydrochloride 98% with best price 56390-09-1 and Epirubicin hydrochloride raw powder

CAS No.: 56390-09-1

Pharmacy Grade

$8.8-10/MT FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.